• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Enhanced Games have not established harm-reduction achievement

by
November 10, 2026
in Health
Reading Time: 3 mins read
0
Enhanced Games have not established harm-reduction achievement

Enhanced Games have not established harm-reduction achievement

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A perspective article published in the Harm Reduction Journal examines the governance conditions required for enhancement-permissive sport to function as a credible harm reduction strategy. The study, authored by Libin Zhang and Xinyou Lv, specifically evaluates the Enhanced Games, a commercial sporting event that publicly permits the use of performance-enhancing substances. This approach directly challenges traditional prohibition-centred anti-doping regimes. The authors argue that the central issue is not simply whether enhancement should be allowed, but rather under what specific governance structures a commercialised model can be considered a legitimate form of harm reduction.

The proponents of the Enhanced Games invoke several key principles to justify their model. They cite transparency, medical supervision, scientific rigor, and athlete autonomy as primary arguments. The core claim is that open and supervised enhancement is less harmful than clandestine, unsupervised use. However, the article distinguishes between the potential for harm reduction and the actual achievement of harm reduction outcomes. The authors note that permission, organiser-reported transparency measures, and structured medical contact may support harm-reduction potential, but these factors alone do not establish that harm reduction has been achieved.

To evaluate the legitimacy of such sports, the article develops a non-compensatory legitimacy test across six distinct domains. These domains include comparative evidentiary adequacy, transparent risk and uncertainty disclosure, independent medical and ethical oversight, non-coercive and revisable consent, longitudinal monitoring and continuing care, and institutional accountability with clear commercial boundaries. The final domain is particularly critical, as it distinguishes between governable conflicts of interest and commercialised risk production. In the latter scenario, commercial actors help shape or normalise bodily risk while retaining insufficient responsibility for the outcomes.

The authors applied this six-domain test to the public record available through 15 August 2026. Their review included registry and filing materials that describe the study design, oversight arrangements, a standard-form athlete agreement, and a five-year follow-up plan. The company behind the Enhanced Games reports that the interventional phase of the study has concluded. However, a significant gap remains in the public record, as the registry posts no study results.

Several critical aspects of the Enhanced Games remain unresolved according to the review. Comparative outcomes remain unresolved. Event-wide exposure rules also remain unresolved. Additionally, the executed contract terms, continuing care provisions, and effective role separation between medical and commercial interests remain unclear.

The article emphasizes the importance of separating formal institutional documentation from organiser-reported claims and external research. It also distinguishes these from unresolved event-specific information and normative inference.

The conclusion of the perspective is that while enhancement-permissive sport may have harm-reduction potential, actual achievement requires more than just permission and basic medical contact. It demands comparative evidence and governance that is independent, transparent, non-coercive, and longitudinally accountable. When applied to the public record of the Enhanced Games, the authors find that the event is only partially evaluable. Consequently, harm-reduction achievement has not been established.

Subject of Research: Legitimacy test for enhancement-permissive sport as harm reduction

Article Title: When can enhancement-permissive sport count as harm reduction? A legitimacy test for the enhanced games

Article References: Zhang, L., & Lv, X. (2026). When can enhancement-permissive sport count as harm reduction? A legitimacy test for the enhanced games. Harm Reduction Journal. https://doi.org/10.1186/s12954-026-01548-1

Image Credits: AI Generated

DOI: 10.1186/s12954-026-01548-1

Keywords: Enhanced Games, Harm Reduction, Performance Enhancement, Sport Governance, Athlete Autonomy, Medical Oversight, Anti-Doping, Commercial Sport, Risk Disclosure, Longitudinal Monitoring, enhancement-permissive, sport

News Source: Glenn Wilkins. (November 10, 2026). Enhanced Games have not established harm-reduction achievement. Scienmag.

Tags: anti-dopingAthlete AutonomyCommercial SportEnhanced Gamesenhancement-permissiveharm reductionlongitudinal monitoringMedical Oversightperformance enhancementRisk Disclosuresportsport governance
Share12Tweet7Share2ShareShareShare1

Related Posts

Postpartum Care Demands Hinder Home Blood Pressure Monitoring

Postpartum Care Demands Hinder Home Blood Pressure Monitoring

November 10, 2026
Fujian Multi-Source Surveillance Tracks Timing and Concordance Across Two COVID-19 Waves

Fujian Multi-Source Surveillance Tracks Timing and Concordance Across Two COVID-19 Waves

November 10, 2026

Impaired Peptide Amidation Enzyme Activity Predicts Incident Alzheimer’s Disease Risk

November 10, 2026

Belgian Study Highlights Follow-Up Gaps in Type 2 Diabetes Care

November 10, 2026

POPULAR NEWS

  • Systematic review identifies barriers to TIVA use

    Systematic review identifies barriers to TIVA use

    29 shares
    Share 12 Tweet 7
  • Early Functional Deterioration Frequent During First-Line Therapy in Advanced Lung Cancer

    29 shares
    Share 12 Tweet 7
  • Metabolomic Signatures Link Cardiovascular Risk in Autoimmune Diseases

    29 shares
    Share 12 Tweet 7
  • Surgical Antibiotic Prophylaxis Nonadherence in Iran Driven by Workflow and Culture

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Postpartum Care Demands Hinder Home Blood Pressure Monitoring

Fujian Multi-Source Surveillance Tracks Timing and Concordance Across Two COVID-19 Waves

Competing Nucleation and Dilution Effects Govern Eggshell Cement Additives, Review Finds

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.